Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma

Detalles Bibliográficos
Autores principales: de Mel, Sanjay, Rashid, Masturah B. M., Zhang, Xi Yun, Goh, Jasmine, Lee, Chun Tsu, Poon, Li Mei, Chan, Esther H. L., Liu, Xin, Chng, Wee Joo, Chee, Yen Lin, Lee, Joanne, Yuen, Yi Ching, Lim, Jing Quan, Chia, Burton K. H., Laurensia, Yurike, Huang, DaChuan, Pang, Wan Lu, Cheah, Daryl Ming Zhe, Wong, Esther Kam Yin, Ong, Choon Kiat, Tang, Tiffany, Lim, Soon Thye, Ng, Siok Bian, Tan, Soo Yong, Loi, Hoi-Yin, Tan, Lip Kun, Chow, Edward K., Jeyasekharan, Anand D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985240/
https://www.ncbi.nlm.nih.gov/pubmed/31988286
http://dx.doi.org/10.1038/s41408-020-0276-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985240/
https://www.ncbi.nlm.nih.gov/pubmed/31988286
http://dx.doi.org/10.1038/s41408-020-0276-7

Ejemplares similares